Showing results (191-200 of 696) with videos related to

Sort By:
Pageof 70
The International Journal of Cardiovascular Imaging|January 23, 2016
Cardiac time intervals and the association with 2D-speckle-tracking, tissue Doppler and conventional echocardiography: the Thousand&1 StudyTor Biering-Sørensen, Jan Skov Jensen, Henrik Ullits Andersen, et al.
British Journal of Clinical Pharmacology|December 30, 2025
The association between mineralocorticoid receptor antagonist use and diabetes occurrence and progression: A systematic review and meta-analysisMehmet Kanbay, Mustafa Guldan, Lasin Ozbek, et al.
Journal of Diabetes and Its Complications|August 13, 2023
Risk of atrial fibrillation in individuals with dysglycemia and diabetesRasmus Rørth, Margit Kriegbaum, Mia Klinten Grand, et al.
Journal of Translational Medicine|August 22, 2025
In silico prediction of optimal multifactorial intervention in chronic kidney diseaseAgnieszka Latosinska, Ioanna K Mina, Thi Minh Nghia Nguyen, et al.
Qualitative Health Research|January 6, 2024
"I Haven't Told Anyone but You": Experiences and Biopsychosocial Support Needs of People With Type 2 Diabetes and Binge EatingPil Lindgreen, Ingrid Willaing, Loa Clausen, et al.
Diabetologia|June 1, 2018
Reduced risk of heart failure with intensified multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: 21 years of follow-up in the randomised Steno-2 studyJens Oellgaard, Peter Gæde, Peter Rossing, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 19, 2024
Summary of Research: Cardiovascular and Kidney Outcomes with Finerenone in Patients with Type 2 Diabetes and Chronic Kidney Disease-The FIDELITY Pooled AnalysisKarin Humle, Boris Klanger, Peter Kolkhof, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 19, 2021
Medical therapies for prevention of cardiovascular and renal events in patients with atrial fibrillation and diabetes mellitusLaurent Fauchier, Giuseppe Boriani, Joris R de Groot, et al.
Kidney International. Supplement|March 9, 2005
Renoprotection with and without blood pressure reductionGozewijn Dirk Laverman, Steen Andersen, Peter Rossing, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2015
IGFBP-4 Fragments as Markers of Cardiovascular Mortality in Type 1 Diabetes Patients With and Without NephropathyRikke Hjortebjerg, Lise Tarnow, Anders Jorsal, et al.
Pageof 70